Skip to main content
Top
Published in: BMC Public Health 1/2022

Open Access 01-12-2022 | Human Papillomavirus | Research

A qualitative descriptive study of providers’ perspectives on human papillomavirus vaccine administration among Latino/a adolescents in South Texas clinics: barriers and facilitators

Authors: Daisy Y. Morales-Campos, Bertha E. Flores, Erin Donovan, Suzanne Burdick, Deborah Parra-Medina, Jessica A. Kahn

Published in: BMC Public Health | Issue 1/2022

Login to get access

Abstract

Background

South Texas Latinas experience higher cervical cancer incidence and mortality compared to Latinas nationwide. Despite the availability of effective human papillomavirus vaccines, South Texas Latino/a adolescents sub-optimally complete the series. Research shows provider recommendation strongly predicts vaccine uptake, but minority adolescents are less likely to report that their provider recommended the vaccine and series completion. There is also scant information on the HPV vaccine administration process in clinic practices providing vaccination services to Latino adolescents with limited access to healthcare resources. The purpose of the study was to describe providers’ experience with administering the HPV vaccine to Latino/a patients in their practices.

Methods

The study used qualitative description to describe the experience of 15 South Texas healthcare providers (doctors and nurses) with the process of HPV vaccine administration in their practices. We conducted open ended, audio-recorded interviews, which were subsequently transcribed verbatim and uploaded into Atlas.(ti) 7.0 for analysis. The interviews yielded detailed descriptions of barriers and facilitators that could potentially impact HPV vaccine uptake.

Results

Providers identified parental exposure to provider recommendation as enhancing HPV acceptance and existing policies and implementation of evidence-based practices as facilitators of HPV vaccine uptake. Barriers ranged from parental fears of adolescent sexual activity and potential vaccine side effects to lack of transportation and the cost of the vaccine.

Conclusion

These findings reflect barriers and facilitators to administering the HPV vaccine previously identified and also highlight issues unique to the situation among Latinos in South Texas. Implications include the need to design and implement efforts to improve provider-parent communication and enhance parental and adolescent patients’ understanding of and confidence in the HPV vaccine. Furthermore, policy changes are needed to rectify organizational/structural challenges to HPV vaccine administration.
Literature
3.
go back to reference Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015;107(6):djv086.CrossRef Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015;107(6):djv086.CrossRef
4.
go back to reference Lin Y, Zhan FB. Geographic variations of racial/ethnic disparities in cervical cancer mortality in Texas. South Med J. 2014;107(5):281–8.PubMed Lin Y, Zhan FB. Geographic variations of racial/ethnic disparities in cervical cancer mortality in Texas. South Med J. 2014;107(5):281–8.PubMed
5.
go back to reference Texas Cancer Registry. Age-Adjusted Cancer Incidence Rates by County in Texas, Cervix Uteri, Hispanic, 2018. Cancer mortality file, Feb 2021. Available from: http://cancer-rates.info/tx/. Accessed 10 Sep 2021. Texas Cancer Registry. Age-Adjusted Cancer Incidence Rates by County in Texas, Cervix Uteri, Hispanic, 2018. Cancer mortality file, Feb 2021. Available from: http://​cancer-rates.​info/​tx/​. Accessed 10 Sep 2021.
6.
go back to reference Texas Cancer Registry. Age-Adjusted Cancer Mortality Rates by County in Texas, Cervix Uteri, Hispanic, 2018. Cancer mortality file, Feb 2021. Available from: http://cancer-rates.info/tx/. Accessed 10 Sep 2021. Texas Cancer Registry. Age-Adjusted Cancer Mortality Rates by County in Texas, Cervix Uteri, Hispanic, 2018. Cancer mortality file, Feb 2021. Available from: http://​cancer-rates.​info/​tx/​. Accessed 10 Sep 2021.
8.
go back to reference Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, et al. HPV vaccination and the risk of invasive cervical Cancer. N Engl J Med. 2020;383(14):1340–8.CrossRef Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, et al. HPV vaccination and the risk of invasive cervical Cancer. N Engl J Med. 2020;383(14):1340–8.CrossRef
9.
go back to reference Melnikow J, Henderson JT, Burda BU, Senger CA, Durbin S, Weyrich MS. Screening for cervical Cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US preventive services task force. JAMA. 2018;320(7):687–705.CrossRef Melnikow J, Henderson JT, Burda BU, Senger CA, Durbin S, Weyrich MS. Screening for cervical Cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US preventive services task force. JAMA. 2018;320(7):687–705.CrossRef
10.
go back to reference Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64(11):300–4.PubMedPubMedCentral Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64(11):300–4.PubMedPubMedCentral
11.
go back to reference Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination - updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2016;65(49):1405–8.CrossRef Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination - updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2016;65(49):1405–8.CrossRef
16.
go back to reference Institute of Medicine (US) Committee on the Evaluation of Vaccine Purchase Financing in the United States. Financing vaccines in the 21st century: assuring access and availability. Washington (DC): National Academies Press (US); 2003. Institute of Medicine (US) Committee on the Evaluation of Vaccine Purchase Financing in the United States. Financing vaccines in the 21st century: assuring access and availability. Washington (DC): National Academies Press (US); 2003.
21.
go back to reference Fernández ME, Allen JD, Mistry R, Kahn JA. Integrating clinical, community, and policy perspectives on human papillomavirus vaccination. Annu Rev Public Health. 2010;31:235–52.CrossRef Fernández ME, Allen JD, Mistry R, Kahn JA. Integrating clinical, community, and policy perspectives on human papillomavirus vaccination. Annu Rev Public Health. 2010;31:235–52.CrossRef
22.
go back to reference Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168(1):76–82.CrossRef Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168(1):76–82.CrossRef
24.
go back to reference Kasting ML, Wilson S, Dixon BE, Downs SM, Kulkarni A, Zimet GD. A qualitative study of healthcare provider awareness and informational needs regarding the nine-valent HPV vaccine. Vaccine. 2016;34(11):1331–4.CrossRef Kasting ML, Wilson S, Dixon BE, Downs SM, Kulkarni A, Zimet GD. A qualitative study of healthcare provider awareness and informational needs regarding the nine-valent HPV vaccine. Vaccine. 2016;34(11):1331–4.CrossRef
25.
go back to reference Perkins RB, Clark JA. Providers’ attitudes toward human papillomavirus vaccination in young men: challenges for implementation of 2011 recommendations. Am J Mens Health. 2012;6(4):320–3.CrossRef Perkins RB, Clark JA. Providers’ attitudes toward human papillomavirus vaccination in young men: challenges for implementation of 2011 recommendations. Am J Mens Health. 2012;6(4):320–3.CrossRef
26.
go back to reference Garbutt JM, Dodd S, Walling E, Lee AA, Kulka K, Lobb R. Barriers and facilitators to HPV vaccination in primary care practices: a mixed methods study using the consolidated framework for implementation research. BMC Fam Pract. 2018;19(1):53.CrossRef Garbutt JM, Dodd S, Walling E, Lee AA, Kulka K, Lobb R. Barriers and facilitators to HPV vaccination in primary care practices: a mixed methods study using the consolidated framework for implementation research. BMC Fam Pract. 2018;19(1):53.CrossRef
27.
go back to reference Bruno DM, Wilson TE, Gany F, Aragones A. Identifying human papillomavirus vaccination practices among primary care providers of minority, low-income and immigrant patient populations. Vaccine. 2014;32(33):4149–54.CrossRef Bruno DM, Wilson TE, Gany F, Aragones A. Identifying human papillomavirus vaccination practices among primary care providers of minority, low-income and immigrant patient populations. Vaccine. 2014;32(33):4149–54.CrossRef
28.
go back to reference Bynum SA, Staras SA, Malo TL, Giuliano AR, Shenkman E, Vadaparampil ST. Factors associated with Medicaid providers’ recommendation of the HPV vaccine to low-income adolescent girls. J Adolesc Health. 2014;54(2):190–6.CrossRef Bynum SA, Staras SA, Malo TL, Giuliano AR, Shenkman E, Vadaparampil ST. Factors associated with Medicaid providers’ recommendation of the HPV vaccine to low-income adolescent girls. J Adolesc Health. 2014;54(2):190–6.CrossRef
29.
go back to reference Jeudin P, Liveright E, Del Carmen MG, Perkins RB. Race, ethnicity, and income factors impacting human papillomavirus vaccination rates. Clin Ther. 2014;36(1):24–37.CrossRef Jeudin P, Liveright E, Del Carmen MG, Perkins RB. Race, ethnicity, and income factors impacting human papillomavirus vaccination rates. Clin Ther. 2014;36(1):24–37.CrossRef
30.
go back to reference Javanbakht M, Stahlman S, Walker S, Gottlieb S, Markowitz L, Liddon N, et al. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community. Vaccine. 2012;30(30):4511–6.CrossRef Javanbakht M, Stahlman S, Walker S, Gottlieb S, Markowitz L, Liddon N, et al. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community. Vaccine. 2012;30(30):4511–6.CrossRef
31.
go back to reference Katz IT, Bogart LM, Fu CM, Liu Y, Cox JE, Samuels RC, et al. Barriers to HPV immunization among blacks and latinos: a qualitative analysis of caregivers, adolescents, and providers. BMC Public Health. 2016;16(1):874.CrossRef Katz IT, Bogart LM, Fu CM, Liu Y, Cox JE, Samuels RC, et al. Barriers to HPV immunization among blacks and latinos: a qualitative analysis of caregivers, adolescents, and providers. BMC Public Health. 2016;16(1):874.CrossRef
32.
go back to reference Kim H, Sefcik JS, Bradway C. Characteristics of qualitative descriptive studies: a systematic review. Res Nurs Health. 2017;40(1):23–42.CrossRef Kim H, Sefcik JS, Bradway C. Characteristics of qualitative descriptive studies: a systematic review. Res Nurs Health. 2017;40(1):23–42.CrossRef
33.
go back to reference Willis DG, Sullivan-Bolyai S, Knafl K, Cohen MZ. Distinguishing features and similarities between descriptive phenomenological and qualitative description research. West J Nurs Res. 2016;38(9):1185–204.CrossRef Willis DG, Sullivan-Bolyai S, Knafl K, Cohen MZ. Distinguishing features and similarities between descriptive phenomenological and qualitative description research. West J Nurs Res. 2016;38(9):1185–204.CrossRef
34.
go back to reference Neergaard MA, Olesen F, Andersen RS, Sondergaard J. Qualitative description - the poor cousin of health research? BMC Med Res Methodol. 2009;9:52.CrossRef Neergaard MA, Olesen F, Andersen RS, Sondergaard J. Qualitative description - the poor cousin of health research? BMC Med Res Methodol. 2009;9:52.CrossRef
35.
go back to reference Morales-Campos DY, Parra-Medina D. Predictors of human papillomavirus vaccine initiation and completion among Latino mothers of 11- to 17-year-old daughters living along the Texas-Mexico border. Fam Community Health. 2017;40(2):139–49.CrossRef Morales-Campos DY, Parra-Medina D. Predictors of human papillomavirus vaccine initiation and completion among Latino mothers of 11- to 17-year-old daughters living along the Texas-Mexico border. Fam Community Health. 2017;40(2):139–49.CrossRef
36.
go back to reference Michael N, O'Callaghan C, Baird A, Hiscock N, Clayton J. Cancer caregivers advocate a patient- and family-centered approach to advance care planning. J Pain Symptom Manag. 2014;47(6):1064–77.CrossRef Michael N, O'Callaghan C, Baird A, Hiscock N, Clayton J. Cancer caregivers advocate a patient- and family-centered approach to advance care planning. J Pain Symptom Manag. 2014;47(6):1064–77.CrossRef
37.
go back to reference Peacock SC, Hammond-Collins K, Forbes DA. The journey with dementia from the perspective of bereaved family caregivers: a qualitative descriptive study. BMC Nurs. 2014;13(1):42.CrossRef Peacock SC, Hammond-Collins K, Forbes DA. The journey with dementia from the perspective of bereaved family caregivers: a qualitative descriptive study. BMC Nurs. 2014;13(1):42.CrossRef
38.
39.
go back to reference Hudson SM, Rondinelli J, Glenn BA, Preciado M, Chao C. Human papillomavirus vaccine series completion: qualitative information from providers within an integrated healthcare organization. Vaccine. 2016;34(30):3515–21.CrossRef Hudson SM, Rondinelli J, Glenn BA, Preciado M, Chao C. Human papillomavirus vaccine series completion: qualitative information from providers within an integrated healthcare organization. Vaccine. 2016;34(30):3515–21.CrossRef
40.
go back to reference Head KJ, Vanderpool RC, Mills LA. Health care providers' perspectives on low HPV vaccine uptake and adherence in Appalachian Kentucky. Public Health Nurs. 2013;30(4):351–60.CrossRef Head KJ, Vanderpool RC, Mills LA. Health care providers' perspectives on low HPV vaccine uptake and adherence in Appalachian Kentucky. Public Health Nurs. 2013;30(4):351–60.CrossRef
41.
go back to reference Morales-Campos DY, Snipes SA, Villarreal EK, Crocker LC, Guerrero A, Fernandez ME. Cervical cancer, human papillomavirus (HPV), and HPV vaccination: exploring gendered perspectives, knowledge, attitudes, and cultural taboos among Mexican American adults. Ethn Health. 2018;26(2):1–19. Morales-Campos DY, Snipes SA, Villarreal EK, Crocker LC, Guerrero A, Fernandez ME. Cervical cancer, human papillomavirus (HPV), and HPV vaccination: exploring gendered perspectives, knowledge, attitudes, and cultural taboos among Mexican American adults. Ethn Health. 2018;26(2):1–19.
42.
go back to reference Morales-Campos DY, Markham CM, Peskin MF, Fernandez ME. Hispanic mothers' and high school girls' perceptions of cervical cancer, human papilloma virus, and the human papilloma virus vaccine. J Adolesc Health. 2013;52(5 Suppl):S69–75.CrossRef Morales-Campos DY, Markham CM, Peskin MF, Fernandez ME. Hispanic mothers' and high school girls' perceptions of cervical cancer, human papilloma virus, and the human papilloma virus vaccine. J Adolesc Health. 2013;52(5 Suppl):S69–75.CrossRef
43.
go back to reference Parra-Medina D, Morales-Campos DY, Mojica C, Ramirez AG. Promotora outreach, education and navigation support for HPV vaccination to Hispanic women with unvaccinated daughters. J Cancer Educ. 2015;30(2):353–9.CrossRef Parra-Medina D, Morales-Campos DY, Mojica C, Ramirez AG. Promotora outreach, education and navigation support for HPV vaccination to Hispanic women with unvaccinated daughters. J Cancer Educ. 2015;30(2):353–9.CrossRef
Metadata
Title
A qualitative descriptive study of providers’ perspectives on human papillomavirus vaccine administration among Latino/a adolescents in South Texas clinics: barriers and facilitators
Authors
Daisy Y. Morales-Campos
Bertha E. Flores
Erin Donovan
Suzanne Burdick
Deborah Parra-Medina
Jessica A. Kahn
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2022
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-022-12837-2

Other articles of this Issue 1/2022

BMC Public Health 1/2022 Go to the issue